Literature DB >> 26098830

Invadopodia: a new therapeutic target to block cancer metastasis.

Konstantin Stoletov1, John D Lewis.   

Abstract

Cancer cells become dangerous when they acquire the ability to invade through physical barriers in the body and disseminate to distant sites. Recent evidence has demonstrated that cancer cells utilize specialized structures called invadopodia, unique protrusions that concentrate proteases such as matrix metalloproteinases (MMPs), to escape blood vessels during the process of extravasation. Perhaps most exciting is the fact that inhibition of invadopodia through genetic or pharmacological means reduces the ability of cancer cells to extravasate and effectively blocks metastasis. This opens the door for the development of novel therapies targeting invadopodia and cancer metastasis.

Entities:  

Keywords:  cancer; cell migration; intravital imaging; invadopodia; metastasis

Mesh:

Substances:

Year:  2015        PMID: 26098830     DOI: 10.1586/14737140.2015.1058711

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  15 in total

1.  EP4 receptor promotes invadopodia and invasion in human breast cancer.

Authors:  Felix Tönisen; Louisiane Perrin; Battuya Bayarmagnai; Koen van den Dries; Alessandra Cambi; Bojana Gligorijevic
Journal:  Eur J Cell Biol       Date:  2017-01-10       Impact factor: 4.492

2.  Persistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration Capacity.

Authors:  Vanessa Maria Pfankuche; Mohamed Sayed-Ahmed; Vanessa Bono Contioso; Ingo Spitzbarth; Karl Rohn; Reiner Ulrich; Ulrich Deschl; Arno Kalkuhl; Wolfgang Baumgärtner; Christina Puff
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

3.  Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog.

Authors:  Armel Herve Nwabo Kamdje; Paul Takam Kamga; Richard Tagne Simo; Lorella Vecchio; Paul Faustin Seke Etet; Jean Marc Muller; Giulio Bassi; Erique Lukong; Raghuveera Kumar Goel; Jeremie Mbo Amvene; Mauro Krampera
Journal:  Cancer Biol Med       Date:  2017-05       Impact factor: 4.248

4.  TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1.

Authors:  Jia-Chun Yang; Yi Zhang; Si-Jia He; Ming-Ming Li; Xiao-Lei Cai; Hui Wang; Lei-Ming Xu; Jia Cao
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

5.  Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.

Authors:  Céline Hoffmann; Xianqing Mao; Joshua Brown-Clay; Flora Moreau; Antoun Al Absi; Hannah Wurzer; Barbara Sousa; Fernando Schmitt; Guy Berchem; Bassam Janji; Clément Thomas
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

6.  Protrudin-mediated ER-endosome contact sites promote MT1-MMP exocytosis and cell invasion.

Authors:  Nina Marie Pedersen; Eva Maria Wenzel; Ling Wang; Sandra Antoine; Philippe Chavrier; Harald Stenmark; Camilla Raiborg
Journal:  J Cell Biol       Date:  2020-08-03       Impact factor: 10.539

Review 7.  Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.

Authors:  Stephan Niland; Andrea Ximena Riscanevo; Johannes Andreas Eble
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 8.  Non-Coding RNAs in Invadopodia: New Insights Into Cancer Metastasis.

Authors:  Feiya Li; Burton B Yang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

9.  LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis.

Authors:  Elaine Ngan; Konstantin Stoletov; Harvey W Smith; Jessica Common; William J Muller; John D Lewis; Peter M Siegel
Journal:  Nat Commun       Date:  2017-04-24       Impact factor: 14.919

10.  TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells.

Authors:  Christian Benzing; Hoyin Lam; Chi Man Tsang; Alexander Rimmer; Yoana Arroyo-Berdugo; Yolanda Calle; Claire M Wells
Journal:  BMC Cancer       Date:  2019-12-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.